Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report)’s stock price fell 8.6% during trading on Tuesday . The company traded as low as $7.62 and last traded at $7.63. 538,704 shares traded hands during trading, a decline of 49% from the average session volume of 1,052,227 shares. The stock had previously closed at $8.35. Wall Street […]
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report)’s share price was up 8% during mid-day trading on Thursday . The company traded as high as $8.24 and last traded at $8.23. Approximately 702,455 shares changed hands during mid-day trading, a decline of 32% from the average daily volume of 1,040,443 shares. The stock had previously closed […]
Acelyrin (NASDAQ:SLRN – Get Free Report) and Pfizer (NYSE:PFE – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends. Analyst Recommendations This is a summary of recent ratings and […]
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month price objective […]
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) has earned an average rating of “Moderate Buy” from the seven analysts that are covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among […]